id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-D-6130-0001,FDA,FDA-2025-D-6130,Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2026-04-20T04:00:00Z,2026,4,2026-04-20T04:00:00Z,,2026-04-20T17:35:59Z,2026-07629,0,0,09000064b9293df3
FDA-2025-D-6130-0002,FDA,FDA-2025-D-6130,Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry,Other,Guidance,2026-04-20T04:00:00Z,2026,4,2026-04-20T04:00:00Z,2026-06-23T03:59:59Z,2026-04-28T09:00:28Z,,1,0,09000064b92940ac